Safety and Immunogenicity of a Newly 23-valent Pneumococcal Polysaccharide Vaccine in Chinese Adults and Children
Clinical trial NCT02285036 · COMPLETED
Trial details
- NCT number
- NCT02285036
- Sponsor
- Walvax Biotechnology Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-09-01
- Primary completion
- 2012-12-01
- Enrollment
- 1660
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.